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Summary 
The activity of angiotensin converting enzyme (ACE) was assessed in human body 
fluids (serum, seminal plasma, prostatic secretions), in tissue extracts of the testis, 
epididymis, prostate and skeletal muscle, in split ejaculates and in seminal plasma 
obtained from patients before and after vasectomy. To ensure the specificity of the 
results the dependence of A C E activity on specific inhibitors was evaluated. 
Enzyme activity found in tissues of the male genital tract was considerably higher 
than that in serum and other tissues. A C E in human seminal plasma is synthesized 
by the testis, epididymis and prostate in different amounts. 
Keywords: A C E in seminal plasma, A C E activity in tissues of the male genital 
tract, origin of A C E activity. 
Introduction 
Angiotensin converting enzyme (E.C.3.4.15.1), a membrane-bound glycoprotein, 
is detectable in all tissues and body fluids of mammals (Soffer, 1976). The enzyme 
plays a key role in the renin-angiotensin-aldosterone system (Peach, 1977). Several 
tissues have been found to contain multiple forms of the enzyme (van Sande, 
Schärpe & Neels, 1985a). A 140 kD form of A C E has been purified from human 
lung, kidney and testis. In addition, the testis contains a 90 kD form of A C E 
(Lanzillo et a l . , 1985), while from seminal plasma, the isolation of a 330 kD enzyme 
has been reported (Depierre, Bargetzi & Roth, 1978). Pulmonary A C E splits off 
the C-terminal dipeptide from the dekapeptide angiotensin I (A-I) to give the 
vasoconstrictor angiotensin II (A-II). The enzyme is able to cleave a variety of 
other peptides not structurally related to A-I (Ondetti & Cushman, 1982). A C E 
involvement in bradykinin inactivation has been demonstrated (Erdös & Yang, 
1966; Ng & Vane, 1968; Kaneko & Moriwaki, 1981). Several natural and synthetic 
peptides have been identified as A C E inhibitors (Depierre, Barge tzi & Roth, 1979; 
Ondetti & Cushman, 1984). The release of C-terminal tripeptides by A C E has also 
been reported (Schärpe et a l . , 1986). 
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The discovery that A C E inhibitors are effective anti-hypertensive drugs 
(Ondetti, Rubin & Cushman, 1977) led to the assumption that this enzyme is 
involved in the regulation of blood pressure. The primary cellular localization of 
A C E is in vascular endothelial cells near the luminal surface, juxtaposed to the 
circulation (Caldwell et a l . , 1976; Vivet, Callard & Gamoudi, 1987). In several 
tissues, A C E is associated with enkephalinase (E.C.3.4.24.11), a neutral metallo-
endopeptidase with similar catalytic properties (Erdös et a l . , 1985). 
The highest A C E activities in man are detectable in prostatic secretions 
(Yokoyama et a l . , 1980) and seminal plasma (Krassnigg et a l . , 1984; van Sande et 
a l . , 1985b) (Table 1). However, its role in fertilization, if any, is unknown. 
Table 1. A C E activity in human body fluids (means ± SD). Numbers in parentheses indicate the 
number of samples assayed 
Body fluid A C E activity (mU/ml) 
Seminal plasma (normozoospermic men) (40) 1980.0 ± 640.7 
Seminal plasma (chronic inflammation of the male genital tract) (72)* 1690.0 ± 864.4 
Prostatic secretions (message via the rectum) (15) 1498.0 ± 19.0 
Serum (males) (36) 37.5 ± 9.0 
Serum (pulmonary sarcoidosis) (34)t 69.0 ± 26.0 
* Significantly different from seminal plasma of normozoospermic men ( P < 0.05) by Mann-Whitney 
(/-test. 
t Significantly different from values in normal serum (Alberts, Van der Schoot & van Daatselaar, 1983). 
To identify the tissues responsible for synthesis and to estimate their 
contribution to A C E activity in seminal plasma, extracts of testis, epididymis and 
prostate were investigated. The results were compared with A C E activity in 
skeletal muscle, serum, seminal plasma, split ejaculates, prostatic secretions and 
seminal plasma obtained from patients before and after vasectomy. 
Materials and methods 
Semen samples a n d tissue p r e t r e a t m e n t 
Semen samples were obtained from patients of the Andrological Outpatient 
Service of the Department of Dermatology, University of Munich, after 4-5 days of 
sexual abstinence (Schirren, 1982). Two hours after liquefaction the samples were 
centrifuged (600 x g, 30 min, 4°C). Seminal plasma was stored until use at -20°C. 
Split ejaculates (Schirren, 1982) and semen obtained from patients before and after 
vasectomy were pretreated identically. Serum was collected from andrological 
patients. Tissue specimens were obtained by open urological surgery. Prostatic fluid 
was obtained by digital massage via the rectum. A l l tissues were frozen in liquid 
nitrogen immediately after receipt. Homogenization of the minced tissues was 
carried out at 0-4°C for 1 min in 0.9% NaCl (2.0 ml/1.0 g of tissue). Debris was 
removed by centrifugation (1500 x g , 60 min, 4°C) and the supernatants were 
analysed for protein concentration and A C E activity. 
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D e t e r m i n a t i o n of A C E a c t i v i t y 
A C E activity was measured according to Cushman & Cheung (1971b). To ensure 
the specifity of the results the dependence of the enzyme activity on proteinase 
inhibitors and the specific A C E inhibitor Captopril was evaluated (Table 2). In all 
A C E activity determinations, hippuryl-L-His-L-Leu (HHL) was used as substrate. 
Non-specific proteolytic activity which could interfere in the assay was suppressed 
by addition of n-butanol (2.5%; v.v) (Hara, Fukuyama & Epstein, 1971). A C E 
activity has been expressed in mU/ml of body fluid (1 U being the amount of 
enzyme that produces 1 |xmol hippuric acid/min) or in mU/mg protein in tissue 
extracts. 
Table 2. Effect of inhibitors on A C E activity in male serum, seminal plasma and in extracts of male 
genital organs 
Serum 
(males) 
Seminal 
plasma Testis 
Tissue extracts 
Epididymis Prostate 
E D T A ( 1 0 ~ 4 mole/1) 0.9 0.6 0.2 0.1 0.5 
Gossypol ( IO - 6 mole/1) 1.1 0.7 0.7 1.3 2.7 
Captopril (10~9 mole/1) 8.4 4.6 1.9 5.5 0.9 
Bradykinin potentiator B (10~3 mole/1) 0.4 1.1 3.8 2.0 1.9 
Data are expressed as the concentration required to inhibit A C T activity by 50%. 
A l l chemicals used in the assays and for pretreatment of the samples were of 
analytical grade. The synthetic A C E substrate H H L was obtained from Bachem 
(Switzerland). Gossypol acetic acid (equimolar crystalline complex) and bradykinin 
potentiator B were purchased from Sigma (USA). Captopril was kindly supplied by 
Squibb-Heyden (Germany). 
D e t e r m i n a t i o n of p r o t e i n c o n c e n t r a t i o n 
Protein concentration was estimated according to Lowry et a l . (1951) using bovine 
serum albumin as standard. 
S t a t i s t i c a l methods 
Data on A C E activity were analysed by the Mann-Whitney Latest. 
Results 
A C E activity was estimated in identically pretreated tissue extracts from 
epididymis, testis, prostate and skeletal muscle, and in seminal plasma, prostatic 
secretions and serum from males. The A C E values determined were regarded as 
specific when more than 90% of the enzyme activity could be inhibited by 10 (xmol/1 
Captopril. In human body fluids great differences in A C E activity were detectable 
(Table 1). The catalytic properties of A C E in body fluids and in male genital organs 
were in good agreement (Table 2). The highest enzyme level in organs from the 
male genital tract was found in prostatic extracts. Epididymis and testis also 
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contained raised levels of A C E activity in comparison to the values detectable in 
extracts of skeletal muscle (Table 3). 
Data obtained from split ejaculates demonstrated that the prostate contributes 
a large amount to the A C E activity in seminal plasma. Thus, the first fraction of the 
split ejaculate, which is derived largely from prostate secretions, contained the 
highest A C E activity (Table 4). 
A C E activity was measured in seminal plasma from vasectomized patients 
before and after surgery. After vasectomy, A C E values decreased significantly, 
suggesting that 43.1 ± 4.7% of the enzyme activity originates from the epididymis 
and testis (Table 5). The estimated A C E activity in prostate secretions obtained 
from urological patients was 1489.0 ± 19.0 mU/ml. In comparison, seminal plasma 
from normozoospermic men contained 2152.0 ± 182.0 mU/ml A C E activity 
(Table 6). 
Table 3. A C E activity (mU/mg protein) in tissue extracts of male genital organs and skeletal muscle 
(means ± SD) 
Epididymis Testis Prostate Skeletal muscle 
A C E activity 16.4 ± 3 . 1 12.5 ± 1.8 28.0 ± 2.5 3.1 ± 1.1 
Protein (mg/ml) 3.7 3.6 3.9 3.8 
Number of samples 14 16 5 5 
Table 4. A C E activity (m iU/1) in split ejaculates ( means ± SD) 
Split ejaculates 
Fraction I Fraction II 
A C E activity 2490.0 ± 902.3 1640.1 ± 788.7 
Range 890-3880.1 460.0-3331.0 
Number of samples 19 19 
Table 5. A C E activity (mU/ml) in seminal plasma obtained from patients before and after vasectomy 
Patient Before After Decrease 
no. vasectomy vasectomy Difference (%) 
1 2156.0 1238.0 918.0 42.6 
2 1970.0 490.0 1480.0 75.0 
3 2212.1 1352.0 860.1 39.0 
4 5170.0 2830.0 2340.0 45.0 
5 2100.0 1130.0 970.0 46.0 
6 1790.0 1360.0 430.0 24.0 
7 2240.0 1195.0 1045.0 47.0 
8 2220.0 1420.0 800.0 36.0 
9 2184.0 1472.0 712.0 33.0 
(mean) 2449.1 1387.4 1061.7 43.1 
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Table 6. Comparison of A C E activity (mU/ml) in prostatic secretions 
and in seminal plasma of normozoospermic men (means ± SD) 
Prostatic secretions Seminal plasma 
A C E activity 1489.0 ± 19.0 2152 ± 182.0 
Range 1470.0-1505.0 1960.0-2324.0 
Number of samples 15 30 
Discussion 
Determination of A C E activity in body fluids and tissues is of diagnostic 
importance in several diseases (Schweisfurth, 1980). Raised levels of A C E in serum 
have been found in sarcoidosis (Silverstein et a l . , 1976). In hyperthyroidism the 
hyperactive thyroid gland is probably not the source of the enhanced A C E values 
(Cushman & Cheung, 1971a). Increased A C E activity in diabetic patients, 
especially those with retinopathy, has also been reported (Lieberman & Sastre, 
1980). As vascular endothelial cells are regarded as sites for A C E synthesis (Ryan 
et a l . , 1975), it is assumed that diffuse vascular damage in diabetic patients could be 
responsible for release of the enzyme into the circulation. The diagnostic 
importance of A C E activity determinations in seminal plasma has been demon-
strated in the evaluation of patients with chronic inflammation of the male 
accessory sex glands (Hohlbrugger, Pschorr & Dahlheim, 1984). Also of diagnostic 
interest are the high A C E levels in benign prostatic hypertrophy (van Sande et a l . , 
1985b). 
In animals, the age-dependent occurrence of A C E in the testis and epididymis is 
well documented (Jaiswal et a l . , 1984). Precise age-related studies have revealed 
that immature male animals have no detectable A C E activity in their genital 
organs. However, the enzyme activity appears when sperm become detectable in 
the testis and epididymis during the course of sexual maturation (Jaiswal et a l . , 
1983). Other investigators have demonstrated the androgen-dependence of A C E 
activity (Rohen, 1978). This is supported by data indicating enhancement of A C E 
activity in the testis of animals by sexual stimulation. This suggests a possible 
involvement of the enzyme in sperm maturation. However, other groups have been 
unable to support these findings, since they demonstrated nearly identical levels of 
A C E activity in the caput and cauda epididymis (Hohlbrugger, Schweisfurth & 
Dahlheim, 1982). The prostate is also the main source for the kininogenase 
kallikrein (tissue kallikrein; E.C.3.4.21.35) of the male genital tract (Fink et a l . , 
1985). Kallikrein is involved in the stimulation of sperm motility (Schill & 
Haberland, 1974). A C E has no comparable effect (Placzek et a l . , 1986). Otherwise 
A-I and A-II seem to enhance sperm motility i n v i t r o comparable to the action of 
bradykinin (Mizutani & Schill, 1985). 
The method used for A C E determination in the present study is regarded as 
highly specific as it enabled determination of enzyme activity in the presence of 
other proteolytic activity. Our results show the highest levels of A C E in prostatic 
tissue and raised levels in the epididymis compared with levels in the testis. This is 
in agreement with the results of immunohistochemical studies (Vivet et a l . , 1987). 
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The levels of A C E activity in prostatic secretions were reduced in comparison to 
seminal plasma, indicating possible contamination of the prostatic fluid with 
secretions from the seminal vesicle. No significant differences in the catalytic 
properties of A C E from the tissues investigated were detectable. The measured 
A C E activity in split ejaculates and in seminal plasma obtained from patients 
before and after vasectomy demonstrates the notable contribution of the testis and 
epididymis to the total A C E activity in seminal plasma. 
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